Agios Pharmaceuticals
AGIO
#5134
Rank
โ‚น152.97 B
Marketcap
โ‚น2,558
Share price
-4.03%
Change (1 day)
13.11%
Change (1 year)

Earnings for Agios Pharmaceuticals (AGIO)

Earnings in 2026 (TTM): -โ‚น42.08 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น98.33 Million. In 2025 the company made an earning of -โ‚น43.76 Billion a decrease over its 2024 earnings that were of -โ‚น39.46 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agios Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น42.08 Billion-3.83%
2025 -โ‚น43.76 Billion10.9%
2024 -โ‚น39.46 Billion8.75%
2023 -โ‚น36.28 Billion0.63%
2022 -โ‚น36.06 Billion2.81%
2021 -โ‚น35.07 Billion10.58%
2020 -โ‚น31.72 Billion-18.41%
2019 -โ‚น38.88 Billion15.72%
2018 -โ‚น33.6 Billion12.99%
2017 -โ‚น29.73 Billion59.61%
2016 -โ‚น18.63 Billion69.32%
2015 -โ‚น11.01 Billion119.28%
2014 -โ‚น5.02 Billion39.22%
2013 -โ‚น3.61 Billion69.1%
2012 -โ‚น2.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น645.72 B-1,618.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น3.222 T-7,674.59%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น663.00 B-1,658.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
-โ‚น10.71 Billion-74.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚น98.77 B-332.20%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น4.04 B-109.51%๐Ÿ‡บ๐Ÿ‡ธ USA